Literature DB >> 31038297

Adult neuroplasticity: A new “cure” for major depression?

Paul R. Albert1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31038297      PMCID： PMC6488487          DOI： 10.1503/jpn.190072

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  68 in total

1.  Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier
Journal:  Neuroscience       Date:  2017-07-13       Impact factor: 3.590

2.  Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.

Authors:  Elizabeth A Bartlett; Christine DeLorenzo; Priya Sharma; Jie Yang; Mengru Zhang; Eva Petkova; Myrna Weissman; Patrick J McGrath; Maurizio Fava; R Todd Ogden; Benji T Kurian; Ashley Malchow; Crystal M Cooper; Joseph M Trombello; Melvin McInnis; Phillip Adams; Maria A Oquendo; Diego A Pizzagalli; Madhukar Trivedi; Ramin V Parsey
Journal:  Neuropsychopharmacology       Date:  2018-06-19       Impact factor: 7.853

3.  Effects of Anodal Transcranial Direct Current Stimulation and Serotonergic Enhancement on Memory Performance in Young and Older Adults.

Authors:  Kristin Prehn; Helena Stengl; Ulrike Grittner; René Kosiolek; Anja Ölschläger; Alexandra Weidemann; Agnes Flöel
Journal:  Neuropsychopharmacology       Date:  2016-08-24       Impact factor: 7.853

4.  Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.

Authors:  Michael F Grunebaum; Hanga C Galfalvy; Tse-Hwei Choo; John G Keilp; Vivek K Moitra; Michelle S Parris; Julia E Marver; Ainsley K Burke; Matthew S Milak; M Elizabeth Sublette; Maria A Oquendo; J John Mann
Journal:  Am J Psychiatry       Date:  2017-12-05       Impact factor: 18.112

Review 5.  Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress.

Authors:  Bruce S McEwen; Lisa Eiland; Richard G Hunter; Melinda M Miller
Journal:  Neuropharmacology       Date:  2011-07-27       Impact factor: 5.250

6.  Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice.

Authors:  Alessandro Ieraci; Alessandro I Madaio; Alessandra Mallei; Francis S Lee; Maurizio Popoli
Journal:  Neuropsychopharmacology       Date:  2016-07-08       Impact factor: 7.853

7.  Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.

Authors:  Dawn F Ionescu; Kate H Bentley; Matthias Eikermann; Norman Taylor; Oluwaseun Akeju; Michaela B Swee; Kara J Pavone; Samuel R Petrie; Christina Dording; David Mischoulon; Jonathan E Alpert; Emery N Brown; Lee Baer; Matthew K Nock; Maurizio Fava; Cristina Cusin
Journal:  J Affect Disord       Date:  2018-09-17       Impact factor: 4.839

8.  Anterior hippocampal volume is reduced in behaviorally depressed female cynomolgus macaques.

Authors:  Stephanie L Willard; David P Friedman; Craig K Henkel; Carol A Shively
Journal:  Psychoneuroendocrinology       Date:  2009-06-02       Impact factor: 4.905

9.  Hippocampal volume and total cell numbers in major depressive disorder.

Authors:  Justin A Cobb; Joy Simpson; Gouri J Mahajan; James C Overholser; George J Jurjus; Lesa Dieter; Nicole Herbst; Warren May; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Psychiatr Res       Date:  2012-11-30       Impact factor: 4.791

Review 10.  Adult neuroplasticity: more than 40 years of research.

Authors:  Eberhard Fuchs; Gabriele Flügge
Journal:  Neural Plast       Date:  2014-05-04       Impact factor: 3.599
View more
  6 in total

Review 1.  Immunological Interfaces: The COVID-19 Pandemic and Depression.

Authors:  Austin Perlmutter
Journal:  Front Neurol       Date:  2021-04-23       Impact factor: 4.003

2.  Longitudinal effects of rTMS on neuroplasticity in chronic treatment-resistant depression.

Authors:  Iris Dalhuisen; Eveline Ackermans; Philip van Eijndhoven; Indira Tendolkar; Lieke Martens; Peter Mulders; Joey Bartholomeus; Alex de Bruijn; Jan Spijker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-09       Impact factor: 5.270

Review 3.  Rewiring of the Serotonin System in Major Depression.

Authors:  Faranak Vahid-Ansari; Paul R Albert
Journal:  Front Psychiatry       Date:  2021-12-16       Impact factor: 4.157

Review 4.  New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity.

Authors:  Clara Rossetti; Antoine Cherix; Laetitia F Guiraud; Jean-René Cardinaux
Journal:  Front Mol Neurosci       Date:  2022-02-15       Impact factor: 5.639

5.  Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression.

Authors:  Amin Zahrai; Faranak Vahid-Ansari; Mireille Daigle; Paul R Albert
Journal:  Transl Psychiatry       Date:  2020-09-30       Impact factor: 6.222

Review 6.  Revisiting Hemispheric Asymmetry in Mood Regulation: Implications for rTMS for Major Depressive Disorder.

Authors:  Benjamin C Gibson; Andrei Vakhtin; Vincent P Clark; Christopher C Abbott; Davin K Quinn
Journal:  Brain Sci       Date:  2022-01-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.